Schedule 13G ownership disclosure

Lipocine Inc.

Security class unavailable · CUSIP: 53630X104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,901,256
Percent of class
5.3600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-20-000059
Form type
SC 13G
Filer
Lipocine Inc.
CIK
CIK 1535955
Filed
Feb 12, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub